236 related articles for article (PubMed ID: 27475753)
1. Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study.
Arnold LM; Schikler KN; Bateman L; Khan T; Pauer L; Bhadra-Brown P; Clair A; Chew ML; Scavone J;
Pediatr Rheumatol Online J; 2016 Jul; 14(1):46. PubMed ID: 27475753
[TBL] [Abstract][Full Text] [Related]
2. An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia.
Pauer L; Winkelmann A; Arsenault P; Jespersen A; Whelan L; Atkinson G; Leon T; Zeiher B;
J Rheumatol; 2011 Dec; 38(12):2643-52. PubMed ID: 21965636
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia.
Mease PJ; Russell IJ; Arnold LM; Florian H; Young JP; Martin SA; Sharma U
J Rheumatol; 2008 Mar; 35(3):502-14. PubMed ID: 18278830
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia.
Ohta H; Oka H; Usui C; Ohkura M; Suzuki M; Nishioka K
Arthritis Res Ther; 2012 Oct; 14(5):R217. PubMed ID: 23062189
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
[TBL] [Abstract][Full Text] [Related]
6. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia.
Arnold LM; Russell IJ; Diri EW; Duan WR; Young JP; Sharma U; Martin SA; Barrett JA; Haig G
J Pain; 2008 Sep; 9(9):792-805. PubMed ID: 18524684
[TBL] [Abstract][Full Text] [Related]
7. Effect of pregabalin on sleep in patients with fibromyalgia and sleep maintenance disturbance: a randomized, placebo-controlled, 2-way crossover polysomnography study.
Roth T; Lankford DA; Bhadra P; Whalen E; Resnick EM
Arthritis Care Res (Hoboken); 2012 Apr; 64(4):597-606. PubMed ID: 22232085
[TBL] [Abstract][Full Text] [Related]
8. Long-term maintenance of response across multiple fibromyalgia symptom domains in a randomized withdrawal study of pregabalin.
Pauer L; Atkinson G; Murphy TK; Petersel D; Zeiher B
Clin J Pain; 2012 Sep; 28(7):609-14. PubMed ID: 22688598
[TBL] [Abstract][Full Text] [Related]
9. Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin.
Crofford LJ; Mease PJ; Simpson SL; Young JP; Martin SA; Haig GM; Sharma U
Pain; 2008 Jun; 136(3):419-431. PubMed ID: 18400400
[TBL] [Abstract][Full Text] [Related]
10. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial.
Crofford LJ; Rowbotham MC; Mease PJ; Russell IJ; Dworkin RH; Corbin AE; Young JP; LaMoreaux LK; Martin SA; Sharma U;
Arthritis Rheum; 2005 Apr; 52(4):1264-73. PubMed ID: 15818684
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of duloxetine 30 mg/d in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study.
Arnold LM; Zhang S; Pangallo BA
Clin J Pain; 2012; 28(9):775-81. PubMed ID: 22971669
[TBL] [Abstract][Full Text] [Related]
13. Safety profile and tolerability of up to 1 year of pregabalin treatment in 3 open-label extension studies in patients with fibromyalgia.
Arnold LM; Emir B; Murphy TK; Zeiher BG; Pauer L; Scott G; Petersel D
Clin Ther; 2012 May; 34(5):1092-102. PubMed ID: 22503162
[TBL] [Abstract][Full Text] [Related]
14. Pregabalin: an alpha2-delta (alpha2-delta) ligand for the management of fibromyalgia.
Arnold L; Mease P; Silverman S
Am J Manag Care; 2010 May; 16(5 Suppl):S138-43. PubMed ID: 20586522
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
16. Correlations between fibromyalgia symptom and function domains and patient global impression of change: a pooled analysis of three randomized, placebo-controlled trials of pregabalin.
Arnold LM; Zlateva G; Sadosky A; Emir B; Whalen E
Pain Med; 2011 Feb; 12(2):260-7. PubMed ID: 21266008
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective.
Choy E; Richards S; Bowrin K; Watson P; Lloyd A; Sadosky A; Zlateva G
Curr Med Res Opin; 2010 Apr; 26(4):965-75. PubMed ID: 20178405
[TBL] [Abstract][Full Text] [Related]
18. The effects of pregabalin on sleep disturbance symptoms among individuals with fibromyalgia syndrome.
Russell IJ; Crofford LJ; Leon T; Cappelleri JC; Bushmakin AG; Whalen E; Barrett JA; Sadosky A
Sleep Med; 2009 Jun; 10(6):604-10. PubMed ID: 19410509
[TBL] [Abstract][Full Text] [Related]
19. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial.
Arnold LM; Goldenberg DL; Stanford SB; Lalonde JK; Sandhu HS; Keck PE; Welge JA; Bishop F; Stanford KE; Hess EV; Hudson JI
Arthritis Rheum; 2007 Apr; 56(4):1336-44. PubMed ID: 17393438
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of esreboxetine in patients with fibromyalgia: a fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial.
Arnold LM; Hirsch I; Sanders P; Ellis A; Hughes B
Arthritis Rheum; 2012 Jul; 64(7):2387-97. PubMed ID: 22275142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
